These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26177032)

  • 1. Differences in Establishment of Persistence of Vaccine and Wild Type Rubella Viruses in Fetal Endothelial Cells.
    Perelygina L; Adebayo A; Metcalfe M; Icenogle J
    PLoS One; 2015; 10(7):e0133267. PubMed ID: 26177032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus.
    Pugachev KV; Galinski MS; Frey TK
    Virology; 2000 Jul; 273(1):189-97. PubMed ID: 10891421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent infection of human fetal endothelial cells with rubella virus.
    Perelygina L; Zheng Q; Metcalfe M; Icenogle J
    PLoS One; 2013; 8(8):e73014. PubMed ID: 23940821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential ability of wild-type and vaccine strains of rubella virus to replicate and persist in human joint tissue.
    Miki NP; Chantler JK
    Clin Exp Rheumatol; 1992; 10(1):3-12. PubMed ID: 1551276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model.
    Cusi MG; Valassina M; Bianchi S; Wunner W; Valensin PE
    Virus Res; 1995 Aug; 37(3):199-208. PubMed ID: 8533457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induction by the Therien and vaccine RA27/3 strains of rubella virus causes depletion of oligodendrocytes from rat neural cell cultures.
    Domegan LM; Atkins GJ
    J Gen Virol; 2002 Sep; 83(Pt 9):2135-2143. PubMed ID: 12185266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic sequence of the RA27/3 vaccine strain of rubella virus.
    Pugachev KV; Abernathy ES; Frey TK
    Arch Virol; 1997; 142(6):1165-80. PubMed ID: 9229006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies.
    Perelygina L; Chen MH; Suppiah S; Adebayo A; Abernathy E; Dorsey M; Bercovitch L; Paris K; White KP; Krol A; Dhossche J; Torshin IY; Saini N; Klimczak LJ; Gordenin DA; Zharkikh A; Plotkin S; Sullivan KE; Icenogle J
    PLoS Pathog; 2019 Oct; 15(10):e1008080. PubMed ID: 31658304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of the full genetic information of Japanese rubella vaccines and the genetic changes associated with in vitro and in vivo vaccine virus phenotypes.
    Otsuki N; Abo H; Kubota T; Mori Y; Umino Y; Okamoto K; Takeda M; Komase K
    Vaccine; 2011 Feb; 29(10):1863-73. PubMed ID: 21251900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of reverse-transcription polymerase chain reaction for detection of rubella virus RNA in cell cultures inoculated with clinical samples.
    Revello MG; Sarasini A; Baldanti F; Percivalle E; Zella D; Gerna G
    New Microbiol; 1997 Jul; 20(3):197-206. PubMed ID: 9258938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella virus: mechanism of attenuation in the vaccine strain (HPV77).
    Nakhasi HL; Zheng D; Callahan L; Dave JR; Liu TY
    Virus Res; 1989 Jul; 13(3):231-43. PubMed ID: 2773598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella virus RNA replication is cis-preferential and synthesis of negative- and positive-strand RNAs is regulated by the processing of nonstructural protein.
    Liang Y; Gillam S
    Virology; 2001 Apr; 282(2):307-19. PubMed ID: 11289813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of rubella virus strain differences associated with attenuation.
    Chantler JK; Lund KD; Miki NP; Berkowitz CA; Tai G
    Intervirology; 1993; 36(4):225-36. PubMed ID: 8169114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency.
    Bodemer C; Sauvage V; Mahlaoui N; Cheval J; Couderc T; Leclerc-Mercier S; Debré M; Pellier I; Gagnieur L; Fraitag S; Fischer A; Blanche S; Lecuit M; Eloit M
    Clin Microbiol Infect; 2014 Oct; 20(10):O656-63. PubMed ID: 24476349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to rubella ribonucleoprotein component after natural infection and after immunization.
    Ho-Terry L; Cohen A
    J Med Microbiol; 1981 Feb; 14(1):141-5. PubMed ID: 7463463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.
    Perelygina L; Hautala T; Seppänen M; Adebayo A; Sullivan KE; Icenogle J
    Antiviral Res; 2017 Nov; 147():58-66. PubMed ID: 28974385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiviral antibody on maintenance of long-term rubella virus persistent infection in Vero cells.
    Abernathy ES; Wang CY; Frey TK
    J Virol; 1990 Oct; 64(10):5183-7. PubMed ID: 2398541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of rubella virus core particles in vero cells.
    Lee JY; Marshall JA; Bowden DS
    Virology; 1999 Dec; 265(1):110-9. PubMed ID: 10603322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History of RA27/3 rubella vaccine.
    Plotkin SA; Buser F
    Rev Infect Dis; 1985; 7 Suppl 1():S77-8. PubMed ID: 3890107
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of rubella virus replication complexes using antibodies to double-stranded RNA.
    Lee JY; Marshall JA; Bowden DS
    Virology; 1994 Apr; 200(1):307-12. PubMed ID: 8128633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.